Related Experiment Video

Updated: Aug 16, 2026

External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

Management of severe pre-eclampsia and eclampsia by UK consultants

J D Hutton1, D K James, G M Stirrat

  • 1Department of Obstetrics and Gynaecology, Wellington School of Medicine, University of Otago, New Zealand.

British Journal of Obstetrics and Gynaecology
|July 1, 1992
PubMed

Insights

UK obstetricians widely use antihypertensive and anticonvulsant drugs for severe pre-eclampsia and eclampsia, but magnesium sulfate use is low. Trials are needed to improve management strategies for these serious pregnancy conditions.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Clinical Pharmacology

Background:

  • Severe pre-eclampsia and eclampsia are critical obstetric emergencies with significant maternal and fetal risks.
  • Current management practices in the UK for these conditions are varied, highlighting a need for standardized approaches.

Purpose of the Study:

  • To assess the contemporary management of severe pre-eclampsia and eclampsia among UK consultant obstetricians.
  • To identify current prescribing patterns for antihypertensive and anticonvulsant medications.

Main Methods:

  • A national one-page postal survey was distributed to 1007 UK consultant obstetricians.
  • The survey collected data on drug use, management strategies, severity criteria, and protocol development for severe pre-eclampsia and eclampsia.

Main Results:

  • A 69.6% response rate was achieved. Oral labetalol, oral methyl dopa, and parenteral hydralazine were common antihypertensives; diuretics were not used. Diazepam was preferred for eclampsia, with very low magnesium sulfate use (2%).
  • 85% of consultants used anticonvulsants prophylactically, primarily diazepam, phenytoin, or chlormethiazole. Two-thirds recognized the need for drug efficacy trials.
  • Inconsistent definitions of severe pre-eclampsia (e.g., headache) and lack of regional protocol review were noted.

Conclusions:

  • While antihypertensive and anticonvulsant therapies are prevalent, there is a consensus on the necessity for clinical trials to validate their effectiveness.
  • Enhancing the management of severe pre-eclampsia and eclampsia may be achieved through greater collective opinion seeking and regional audit of obstetric protocols in the UK.
Abstract

More Related Videos

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting05:33

Ear Plaster Therapy as a Safe and Effective Treatment for Gestational Vomiting

Published on: August 4, 2023

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...